Trending...
- Leadership in Democracy Cohort 2021 Announced
- Decorating "Things" has never been easier!
- Press 'Reset' For 2021 With New 'Cosmic Love Letters' Horoscopes
CHICAGO, Nov. 26, 2020 /PRNewswire/ -- BASE10 Genetics and DNA Link today announced their collaboration on a research project to evaluate the usability of DNA Link's AccuFind COVID-19 IgG antibody test in a healthcare setting.
Although Covid-19 deaths and new confirmed cases continue to rise across nursing homes in the US, many of those infected do recover. This has led to growing interest in the relationship between antibodies and their protective value whether generated by previous Covid-19 exposure or by a vaccine, once available.
At present, most antibody tests on the market require samples to be sent to a lab for analysis. The extra cost and time associated has constrained population wide studies of SARS-CoV-2 antibodies.
"An antibody test that can be done at the point of care without the need for a lab can more quickly provide information clinicians and administrators need to make decisions for their nursing home patients and staff," says Dr. Michael Fang, BASE10 CEO.
More on illi News
"This research is an important milestone in our efforts to expand access to antibody testing," says Elizabeth Freund, VP of Innovation at BASE10. "DNA Link's AccuFind performs very well in laboratory settings. The next logical step is to test its performance when used by healthcare professionals outside the lab. Many factors have the potential to affect test performance in lesser controlled settings so it's an ambitious goal to be sure. However, if FDA believes the data demonstrates its safety and effectiveness under these conditions, we'll be one step closer to FDA emergency use authorization for point of care use."
The study is set to launch in December.
About BASE10 Genetics, Inc.
BASE10 is a precision medicine company based in Chicago. BASE10's proprietary platform identifies precision diagnostics technologies with high potential for improving health outcomes, and creates turnkey, disease management programs that can be deployed at scale for insurance payors.
More on illi News
For more information about BASE10 Genetics and its solutions, contact [email protected].
About DNA Link, Inc.
DNA Link, Inc. is a leading genomic service corporation based in Korea with a focus on personalized medicine and new drug development. The company combines biotechnology with information & communications technology to support total analysis of genomic and clinical information to accelerate research and development in the field of bio-industry and genomic analysis industry.
For more information about DNA Link and its solutions, contact [email protected]
SOURCE BASE10 Genetics, Inc.
Related Links
https://www.base10genetics.com/
Although Covid-19 deaths and new confirmed cases continue to rise across nursing homes in the US, many of those infected do recover. This has led to growing interest in the relationship between antibodies and their protective value whether generated by previous Covid-19 exposure or by a vaccine, once available.
At present, most antibody tests on the market require samples to be sent to a lab for analysis. The extra cost and time associated has constrained population wide studies of SARS-CoV-2 antibodies.
"An antibody test that can be done at the point of care without the need for a lab can more quickly provide information clinicians and administrators need to make decisions for their nursing home patients and staff," says Dr. Michael Fang, BASE10 CEO.
More on illi News
- Brazil's ANVISA Grants Novel Food Approval for NEM® brand eggshell membrane
- CreditSnap, a next generation FinTech startup, announces strategic seed investment from multi-lender finance platform Tresl, its earliest adopter
- Hilco Redevelopment Partners' Cori Rosales Accepted to the Chicago City Council Latino Caucus Foundation Leadership Academy 2021 Cohort
- Qué es el Marketing Science y por qué es indispensable considerarlo en el 2021
- Sterling Trading Tech Processed A Record 8.2% Of All Traded US Stock Volume
"This research is an important milestone in our efforts to expand access to antibody testing," says Elizabeth Freund, VP of Innovation at BASE10. "DNA Link's AccuFind performs very well in laboratory settings. The next logical step is to test its performance when used by healthcare professionals outside the lab. Many factors have the potential to affect test performance in lesser controlled settings so it's an ambitious goal to be sure. However, if FDA believes the data demonstrates its safety and effectiveness under these conditions, we'll be one step closer to FDA emergency use authorization for point of care use."
The study is set to launch in December.
About BASE10 Genetics, Inc.
BASE10 is a precision medicine company based in Chicago. BASE10's proprietary platform identifies precision diagnostics technologies with high potential for improving health outcomes, and creates turnkey, disease management programs that can be deployed at scale for insurance payors.
More on illi News
- eHealth Market worth $193.8 billion by 2025 - Exclusive Report by MarketsandMarkets™
- Aesthetic Mentor Hosts Free Webinar "Becoming an Aesthetic Nurse in 2021"
- Affinitiv and Gubagoo Partner to Integrate Trade-In Valet Express into Digital Retailing Solution
- Process Technology announces advanced heating for IPA and flammable solvents with two new heaters
- Syxsense Announces the Release of Syxsense Cortex, A Next-Generation, Visual IT and Security Management Process Automation Solution
For more information about BASE10 Genetics and its solutions, contact [email protected].
About DNA Link, Inc.
DNA Link, Inc. is a leading genomic service corporation based in Korea with a focus on personalized medicine and new drug development. The company combines biotechnology with information & communications technology to support total analysis of genomic and clinical information to accelerate research and development in the field of bio-industry and genomic analysis industry.
For more information about DNA Link and its solutions, contact [email protected]
SOURCE BASE10 Genetics, Inc.
Related Links
https://www.base10genetics.com/
Filed Under: Business
0 Comments
Latest on illi News
- Cardinal Dolan offers lessons of hope and courage in new book for Lent
- White Palms Fire Equipment Doubles Down on Online Presence By Hiring Leading Digital Marketing Company, Simply the Best Digital
- Silver Glen Senior Living Opens Doors to Residents in South Elgin, Illinois
- ACAMS' 4th Anti-Financial Crime Conference – Africa to Host Leading Compliance Experts on Region's Greatest Emerging Regulatory Risks
- Aon finds climate-influenced weather is key driver of $268B global damage from 2020 natural disasters with 64% uninsured
- Catch The Vibe: Astrologer Anne on Vibe Selection Podcast
- It's Undebatable: Astrologer Anne Shines On Super Fun Podcast
- Prism Health Lab Opens Their 6th Location at the Chinatown Branch of the Chicago Public Library, Enabling Easily Accessible COVID-19 Testing
- Six Features a D3P Needs to Make the Cloud 17a-4 Compliant
- Prime Law Group Hires New Attorney Mario J. Sankis
- Air Fry Plus: Enjoy Convenience And Style With Premium Kitchen Supplies
- Motorola Solutions to Issue Fourth-Quarter and Full-Year 2020 Earnings Results on Feb. 4
- Royal DSM Selects MAAG Group for Expansion in Strand Pelletizing Business
- Using Pandemic Lessons and Risk Assessments to Prepare for PCI DSS 4.0
- Press 'Reset' For 2021 With New 'Cosmic Love Letters' Horoscopes
- Kaizen Finance Launches Staking to Foster the Widespread Adoption of DeFi
- Ismail Sirdah Describes the Best Practices for Holding Corporate Events
- MDAdvantage Appoints Pete Cammarano to Board of Directors
- Leadership in Democracy Cohort 2021 Announced
- CEO Coaching International Congratulates Client Orion Energy on Successful Capital Partnerships